Descrizione

Stool consistency outcomes from the FOS supplementation trial in constipated infants. The placebo-controlled data indicate changes in stool characteristics following fructooligosaccharide administration.

Figure 2

Chart

Source Paper

Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation.

Nutrients (2018)

PMID: 30388751

DOI: 10.3390/nu10111602

Cite This Figure

![Figure 2: Stool consistency outcomes from the FOS supplementation trial in constipated infants. The placebo-controlled data indicate changes in stool characteristics following fructooligosaccharide administration.]()

> Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." *Nutrients*, 2018. PMID: [30388751](https://pubmed.ncbi.nlm.nih.gov/30388751/)

<figure>
  <img src="" alt="Stool consistency outcomes from the FOS supplementation trial in constipated infants. The placebo-controlled data indicate changes in stool characteristics following fructooligosaccharide administration." />
  <figcaption>Figure 2. Stool consistency outcomes from the FOS supplementation trial in constipated infants. The placebo-controlled data indicate changes in stool characteristics following fructooligosaccharide administration.<br>  Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30388751/">30388751</a></figcaption>
</figure>

Evidenze correlate

Fructooligosaccharides (FOS) per Chronic Constipation

Grado C · 4 studi